ta 993 has been researched along with pentoxifylline in 1 studies
| Studies (ta 993) | Trials (ta 993) | Recent Studies (post-2010) (ta 993) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 4,437 | 657 | 943 |
| Protein | Taxonomy | ta 993 (IC50) | pentoxifylline (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 6.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, H; Inoue, H; Kaburaki, M; Narita, H; Suzumura, K | 1 |
1 other study(ies) available for ta 993 and pentoxifylline
| Article | Year |
|---|---|
Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia.
Topics: Animals; Blood Pressure; Blood Viscosity; Diltiazem; Heart Rate; Hindlimb; Ischemia; Muscle Fatigue; Pentoxifylline; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 2000 |